These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 28090673)

  • 1. Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.
    Wang H; Liao C; Ding K; Zhang L; Wang L
    BMC Vet Res; 2024 Jun; 20(1):241. PubMed ID: 38831324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.
    Lu TY; Sun Z; Liang LY; Zhang J; Guo WL; Wang ZY; Sun J; Liao XP; Zhou YF
    J Appl Microbiol; 2024 Jul; 135(7):. PubMed ID: 38925653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis.
    Wei XY; Zhang J; Zhang Y; Fu WZ; Zhong LG; Pan YD; Sun J; Liao XP; Liu YH; Zhou YF
    BMC Vet Res; 2024 Apr; 20(1):147. PubMed ID: 38643185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung microdialysis and
    Chen Y; Li M; Su D; Xiong S; Feng Y; Deng Q; Ding H
    Front Vet Sci; 2024; 11():1390336. PubMed ID: 38596468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome perturbation and its correlation with tylosin pharmacokinetics in healthy and infected pigs.
    Lee EB; Lee GY; Hossain MA; Awji EG; Park SC
    Sci Rep; 2024 Aug; 14(1):18670. PubMed ID: 39134586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility evaluation and PK/PD integration of tulathromycin against
    Wang H; Zhang L
    Front Vet Sci; 2024; 11():1407907. PubMed ID: 39051006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PK-PD Integration Modeling and Cutoff Value of Florfenicol against
    Lei Z; Liu Q; Yang S; Yang B; Khaliq H; Li K; Ahmed S; Sajid A; Zhang B; Chen P; Qiu Y; Cao J; He Q
    Front Pharmacol; 2018; 9():2. PubMed ID: 29387013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Antimicrobial Activity of Colistin in Combination With Gamithromycin Against
    Li Y; Xie M; Zhou J; Lin H; Xiao T; Wu L; Ding H; Fang B
    Front Microbiol; 2020; 11():511356. PubMed ID: 33072002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Pharmacokinetics of Gentamicin C
    Kim EY; Kim TW; Awji EG; Lee EB; Park SC
    Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hollow-fibre infection model: adaptations for the culture and assessment of fastidious organisms.
    Mead A; Azzariti S; Pelligand L
    Access Microbiol; 2024; 6(6):. PubMed ID: 39045245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behaviour and pharmacokinetic-pharmacodynamic integration of doxycycline in rainbow trout (Oncorhynchus mykiss) after intravascular, intramuscular and oral administrations.
    Altan F; Corum O; Durna Corum D; Uney K; Terzi E; Bilen S; Sonmez AY; Elmas M
    Vet Med Sci; 2024 May; 10(3):e1419. PubMed ID: 38520701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic integration of tilmicosin against
    Chen Y; Ji X; Zhang S; Wang W; Zhang H; Ding H
    Front Vet Sci; 2023; 10():1260990. PubMed ID: 37732140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models.
    Zhang L; Xie H; Wang Y; Wang H; Hu J; Zhang G
    Front Vet Sci; 2022; 9():860472. PubMed ID: 35400105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kill Rate and Evaluation of
    Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
    Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Rattanapanadda P; Kuo HC; Vickroy TW; Sung CH; Rairat T; Lin TL; Yeh SY; Chou CC
    Front Microbiol; 2019; 10():2430. PubMed ID: 31749775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of water hardness on oxytetracycline oral bioavailability in fed and fasted piglets.
    Decundo JM; Diéguez SN; Martínez G; Romanelli A; Fernández Paggi MB; Pérez Gaudio DS; Amanto FA; Soraci AL
    Vet Med Sci; 2019 Nov; 5(4):517-525. PubMed ID: 31282118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Regimens and Cutoff Evaluation of Tildipirosin Against
    Lei Z; Liu Q; Qi Y; Yang B; Khaliq H; Xiong J; Moku GK; Ahmed S; Li K; Zhang H; Zhang W; Cao J; He Q
    Front Pharmacol; 2018; 9():765. PubMed ID: 30093860
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
    Dorey L; Hobson S; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.